0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editorial |  May 01, 2013
HPV Vaccination:  Too Soon for 2 Doses?
Jessica A. Kahn, MD, MPH; David I. Bernstein, MD, MA
JAMA. 2013;309(17):1832-1834. doi:10.1001/jama.2013.4147.
Original Contribution |  May 01, 2013
Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women:  A Randomized Clinical Trial
Simon R. M. Dobson, MD; Shelly McNeil, MD; Marc Dionne, MD; et al.
JAMA. 2013;309(17):1793-1802. doi:10.1001/jama.2013.1625.
INCLUDES: , Supplemental Content
From the Centers for Disease Control and Prevention |  August 01, 2012 FREE
Human Papillomavirus–Associated Cancers—United States, 2004-2008
JAMA. 2012;308(5):445-447. doi:.
Editorial |  February 15, 2012
Oral Human Papillomavirus Infection:  Hazard of Intimacy
Hans P. Schlecht, MD, MMSc
JAMA. 2012;307(7):724-725. doi:10.1001/jama.2012.117.
Original Contribution |  February 15, 2012 FREE
Prevalence of Oral HPV Infection in the United States, 2009-2010
Maura L. Gillison, MD, PhD; Tatevik Broutian, MS; Robert K. L. Pickard, EdM, MS, MPH; et al.
JAMA. 2012;307(7):693-703. doi:10.1001/jama.2012.101.
INCLUDES: , Supplemental Content
From the Centers for Disease Control and Prevention |  February 08, 2012 FREE
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males—Advisory Committee on Immunization Practices (ACIP), 2011
JAMA. 2012;307(6):557-559. doi:.
Commentary |  October 19, 2011
Mandatory HPV Vaccination and Political Debate
Lawrence O. Gostin, JD
JAMA. 2011;306(15):1699-1700. doi:10.1001/jama.2011.1525.
Original Contribution |  April 13, 2011 FREE
Immunogenicity and Reactogenicity of Alternative Schedules of HPV Vaccine in Vietnam:  A Cluster Randomized Noninferiority Trial
Kathleen M. Neuzil, MD, MPH; Do Gia Canh, MD; Vu Dinh Thiem, MD; et al.
JAMA. 2011;305(14):1424-1431. doi:10.1001/jama.2011.407.
INCLUDES: , Supplemental Content
Health Agencies Update |  February 23, 2011
New HPV Vaccine Indication
Bridget M. Kuehn
JAMA. 2011;305(8):770. doi:10.1001/jama.2011.180.
From the Centers for Disease Control and Prevention |  August 11, 2010 FREE
FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations From the Advisory Committee on Immunization Practices (ACIP)
JAMA. 2010;304(6):632-634. doi:.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Dermatology
Correspondence  |  Mar 2013
Complete Resolution of Chronic Multiple Verruca Vulgaris Treated With Quadrivalent Human Papillomavirus Vaccine
Benjamin S. Daniel, BA, BCom, MBBS; Dedee F. Murrell, BMBCh, MD, FACD
JAMA Otolaryngology–Head & Neck Surgery
Original Article  |  Dec 2012
Predicting HPV Status in Head and Neck Cancer:  The Predictive Value of Sociodemographic and Disease Characteristics
J. Kenneth Byrd, MD; Christina S. T. Wilhoit, CCRP; M. Taylor Fordham, MD; et al.
JAMA Pediatrics
Article  |  Dec 2012
Safety of Quadrivalent Human Papillomavirus Vaccine Administered Routinely to Females
Nicola P. Klein, MD, PhD; John Hansen, MPH; Chun Chao, PhD; et al.
JAMA Otolaryngology–Head & Neck Surgery
Original Article  |  Nov 2012
Retrospective Review of Positron Emission Tomography With Contrast-Enhanced Computed Tomography in the Posttreatment Setting in Human Papillomavirus–Associated Oropharyngeal Carcinoma
Jason Y. K. Chan, MBBS; Giuseppe Sanguineti, MD; Jeremy D. Richmon, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems